Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2013

View Archived Issues

Identification and suppression of the neuronal circuitry underlying compulsive behavior

Studies characterize activity of Alzheimer's disease candidate RO-4602522

Effects of AZD-5213 on sleep evaluated in patients with MCI and Alzheimer's disease

GlaxoSmithKline profiles pipeline progress of second quarter 2013

Memory improvements seen with insulin detemir in Alzheimer's disease, mild cognitive impairment

Hemophilia candidate concizumab evaluated in phase I trial

Sanofi researchers report antibodies targeting IL-13

New GPR119 receptor agonists patented by Hyundai Pharmaceutical

The Terasaki Family Foundation prepares novel IVIg mimetics

FDA grants market authorization for Cepheid's tuberculosis test

Vertex provides update on ongoing VX-135 trials in hepatitis C

Yakult Honsha begins phase I/II study of resminostat in NSCLC

EMA committee recommends Defitelio approval under exceptional circumstances

EMA's CHMP recommends approval of VEGF Trap-Eye/Eylea for new indication

PolyTherics merges with Antitope

Phosphagenics reaches milestone in development program for TPM/oxycodone patch

Genesis Biopharma and Lion Biotechnologies complete merger

EMA committee recommends approval of Revolade expanded indication

EMA issues negative opinion on delamanid for tuberculosis

Captisol-enabled topiramate injection receives FDA orphan drug status

Adimab licenses antibody discovery platform to Biogen Idec and GSK

Novartis' dual bronchodilator QVA-149 recommended for approval in COPD by CHMP

Gilead receives positive opinion from EMA for cobicistat

EMA committee recommends approval of three Takeda type 2 diabetes therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...